Pure Global AI
Disease / condition

Nasopharyngeal Carcinoma clinical trials

Free access to 325 studies10+ countriesUpdated daily86 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
325
Total trials
10+
Countries
10+
Sponsors
86
Recruiting
By phase
Phase 2130
N/A78
Phase 374
Phase 118
Early Phase 113
By status
Recruiting86
Not yet recruit...74
Unknown74
Completed67
Terminated10
Top countries
China244
Taiwan11
Singapore9
United States of America5
Malaysia3
Top sponsors
Sun Yat-sen Univer...93
Zhejiang Cancer Ho...16
Fudan University15
Fujian Cancer Hosp...10
Wei Jiang7
Recent trials
Latest clinical trials for Nasopharyngeal Carcinoma
Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients
Affiliated Hospital of Nantong... · China
NCT06389201Not yet recr...
Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.
XIANG YANQUN · China
NCT06383780Recruiting
Phase
Phase 3
KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical Trial
Sun Yat-sen University · China
NCT06370026Not yet recr...
Phase
Phase 1
Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
NCT06364826Not yet recr...
Phase
Phase 2
SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma
Sun Yat-sen University · China
NCT06323239Not yet recr...
Phase
Phase 2
TPC Versus GP Induction Chemotherapy for Nasopharyngeal Carcinoma
Sun Yat-sen University · China
NCT06301165Recruiting
Phase
Phase 2
Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
Jiangxi Provincial Cancer Hosp... · China
NCT06259721Recruiting
Phase
Phase 2
Intermittent Oral-esophageal Tube in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma
Zeng Changhao · China
NCT06248840Terminated
Individualized Elective Neck Irradiation in NPC Patients
Sun Yat-sen University
NCT06241612Not yet recr...
Phase
Phase 3
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response
Sun Yat-sen University · China
NCT06239727Not yet recr...
Phase
Phase 3
PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy
Fudan University · China
NCT06156878Recruiting
Phase
Phase 2
Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life
Fujian Cancer Hospital · China
NCT06136962Not yet recr...
Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging
Fifth Affiliated Hospital, Sun... · China
NCT06129201Not yet recr...
A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Sichuan Baili Pharmaceutical C... · China
NCT06118333Not yet recr...
Phase
Phase 3
Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC
Fujian Cancer Hospital · China
NCT06095167Not yet recr...
Phase
Phase 3
KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial
Kousai Bio Co., Ltd. · China
NCT06097793Not yet recr...
Phase
Phase 1
Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma
National Cancer Centre, Singap... · Singapore
NCT06093061Not yet recr...
Phase
Phase 2
Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
Chongqing University Cancer Ho...
NCT06059261Not yet recr...
Phase
Phase 2
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
National Cancer Institute (NCI...
NCT06029270Not yet recr...
Phase
Phase 2
GNT Induction Treatment in Locally Advanced NPC
Air Force Military Medical Uni... · China
NCT06026878Recruiting
Phase
Phase 3
About this profile

Access comprehensive clinical trial information for Nasopharyngeal Carcinoma through Pure Global AI's free database. This collection includes 325 clinical trials across multiple phases including Phase 2, N/A, Phase 3. Currently, 86 trials are actively recruiting participants.

Research for Nasopharyngeal Carcinoma is being conducted in China, Taiwan, Singapore and 7+ other countries. Leading sponsors include Sun Yat-sen University and Zhejiang Cancer Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 325 clinical trials studying Nasopharyngeal Carcinoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Sun Yat-sen University, Zhejiang Cancer Hospital, Fudan University, among others.